Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 88

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

A Multifunctional Envelope-type Nanodevice for Use in Nanomedicine: Concept and Applications

Nakamura, T., Akita, H., Yamada, Y., Hatakeyama, H., Harashima, H. · 2012 · Accounts of Chemical Research

Abstract

In the 21st century, drug development has shifted toward larger molecules such as proteins and nucleic acids, which require the use of new chemical strategies. In this process, the drug delivery system plays a central role and intracellular targeting using nanotechnology has become a key technology for the development of successful new medicines. We have developed a new delivery system, a multifunctional envelope-type nanodevice (MEND) based on "Programmed Packaging." In this new concept of packaging, multifunctional nanodevices are integrated into a nanocarrier system according to a program designed to overcome all barriers during the course of biodistribution and intracellular trafficking. In this Account, we introduce our method for delivering nucleic acids or proteins to intracellular sites of action such as the cytosol, nucleus, and mitochondria and for targeting selective tissues in vivo via systemic administration of the nanodevices. First, we introduce an octaarginine-modified MEND (R8-MEND) as an efficient intracellular delivery system, designed especially for vaccinations and transgene expression. Many types of cells can internalize the R8-MEND, mainly by inducing macropinocytosis, and the MEND escapes from macropinosomes via membrane fusion, which leads to efficient antigen presentation via the major histocompatibility complex I pathway in antigen-presenting cells. In addition, the transfection activities of the R8-MEND in dividing cells, such as HeLa or A549 cells…

Overview

Integrity signals

Registry

Crossref · 10.1021/ar200254s

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 37

  1. Kogure K., 2008, Adv. Drug Delivery Rev., 60, 559, 10.1016/j.addr.2007.10.007 · DOI · Paper page
  2. Hatakeyama H., 2011, Adv. Drug Delivery Rev., 63, 152, 10.1016/j.addr.2010.09.001 · DOI · Paper page
  3. Futaki S., 2001, Bioconjugate Chem., 12, 1005, 10.1021/bc015508l · DOI · Paper page
  4. Khalil I. A., 2006, J. Biol. Chem., 281, 3544, 10.1074/jbc.M503202200 · DOI · Paper page
  5. Khalil I. A., 2006, Pharmacol. Rev., 58, 32, 10.1124/pr.58.1.8 · DOI · Paper page
  6. El-Sayed A., 2008, J. Biol. Chem., 283, 23450, 10.1074/jbc.M709387200 · DOI · Paper page
  7. Nakamura T., 2008, Mol. Ther., 16, 1507, 10.1038/mt.2008.122 · DOI
  8. Homhuan A., 2007, J. Controlled Release, 120, 60, 10.1016/j.jconrel.2007.03.017 · DOI
  9. Joraku A., 2009, BJU Int., 103, 686, 10.1111/j.1464-410X.2008.08235.x · doi:10.1111/j.1464-410x.2008.08235.x
  10. Kogure K., 2004, J. Controlled Release, 98, 317, 10.1016/j.jconrel.2004.04.024 · DOI · Paper page
  11. Khalil I. A., 2007, Gene Ther., 14, 682, 10.1038/sj.gt.3302910 · DOI · Paper page
  12. Nakamura Y., 2007, J. Controlled Release, 119, 360, 10.1016/j.jconrel.2007.03.010 · DOI · Paper page
  13. Subramanian A., 1999, Nat. Biotechnol., 17, 873, 10.1038/12860 · DOI · Paper page
  14. Akita H., 2010, Mol. Ther., 18, 955, 10.1038/mt.2010.33 · DOI
  15. Akita H., 2009, Biomaterials, 30, 2940, 10.1016/j.biomaterials.2009.02.009 · DOI
  16. Shaheen, S. M.; Akita, H.; Nakamura, T.; Takayama, S.; Futaki, S.; Yamashita, A.; Katoono, R.; Yui, N.; Harashima, H.KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.Biomaterials 2012, in press. · DOI
  17. Hama S., 2007, Nucleic Acids Res., 35, 1533, 10.1093/nar/gkl1165 · DOI
  18. Hama S., 2006, Mol. Ther., 13, 786, 10.1016/j.ymthe.2005.10.007 · DOI · Paper page
  19. Shaheen S. M., 2011, Nucleic Acids Res., 39, e48, 10.1093/nar/gkq1327 · DOI
  20. Yamashita A., 2008, J. Controlled Release, 131, 137, 10.1016/j.jconrel.2008.07.011 · doi:10.1016/j.jconrel.2008.07.011
  21. Holt I. J., 1988, Nature, 331, 717, 10.1038/331717a0 · DOI · Paper page
  22. Zhang E., 2011, Drug Discovery Today, 16, 140, 10.1016/j.drudis.2010.12.006 · DOI
  23. Flierl A., 2003, Mol. Ther., 7, 550, 10.1016/S1525-0016(03)00037-6 · DOI
  24. D’Souza G. G., 2005, Mitochondrion, 5, 352, 10.1016/j.mito.2005.07.001 · DOI
  25. Yamada Y., 2008, Biochim. Biophys. Acta, 1778, 423, 10.1016/j.bbamem.2007.11.002 · DOI · Paper page
  26. Yasuzaki Y., 2010, Biochem. Biophys. Res. Commun., 397, 181, 10.1016/j.bbrc.2010.05.070 · DOI
  27. Yamada Y., 2011, Mol. Ther., 19, 1449, 10.1038/mt.2011.99 · DOI
  28. Yamada, Y.; Harashima, H.Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter.Biomaterials 2012, in press. · DOI
  29. Matsumura Y., 1986, Cancer Res., 46, 6387
  30. Klibanov A. L., 1990, FEBS Lett., 268, 235, 10.1016/0014-5793(90)81016-H · DOI · Paper page
  31. Mishra S., 2004, Eur. J. Cell Biol., 83, 97, 10.1078/0171-9335-00363 · DOI · Paper page
  32. Hatakeyama H., 2007, Gene Ther., 14, 68, 10.1038/sj.gt.3302843 · DOI · Paper page
  33. Hatakeyama H., 2011, Biomaterials, 32, 4306, 10.1016/j.biomaterials.2011.02.045 · DOI · Paper page
  34. Hafez I. M., 2001, Adv. Drug Delivery Rev., 47, 139, 10.1016/S0169-409X(01)00103-X · DOI · Paper page
  35. Hatakeyama H., 2009, J. Controlled Release, 139, 127, 10.1016/j.jconrel.2009.06.008 · DOI · Paper page
  36. Sakurai Y., 2009, Biol. Pharm. Bull., 32, 928, 10.1248/bpb.32.928 · DOI
  37. Sakurai Y., 2011, Biomaterials, 32, 5733, 10.1016/j.biomaterials.2011.04.047 · DOI

Cited by

See all 88

Metadata

Authors
Nakamura, T., Akita, H., Yamada, Y., Hatakeyama, H., & Harashima, H.
Affiliations
Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Sapporo City, Hokkaido 060-0812, Japan
Venue
Accounts of Chemical Research
Published
2012-02-10
Volume
45
Issue
7
Pages
1113-1121
ISSN
  • 0001-4842
  • 1520-4898
Cited by
88
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.